Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Osteoarthritis Drugs Market

Osteoarthritis Drugs Market Size

  • Report ID: GMI8580
  • Published Date: Mar 2024
  • Report Format: PDF

Osteoarthritis Drugs Market Size

Osteoarthritis Drugs Market was valued at USD 8.9 billion in 2023 and is expected to reach USD 16.1 billion by end of 2032, growing at a CAGR of 6.9% over the analysis period. The industry is experiencing dynamic growth driven by factors such as increasing prevalence of osteoarthritis majorly among geriatric population and growing research & development activities for osteoarthritis therapeutics.


According to the data published by Centers for Disease Control and Prevention in 2023, approximately 32.5 million people have osteoarthritis in the U.S. alone. Therefore, advancement in treatment of osteoarthritis and drug development, introduction of personalized osteoarthritis new medications and enhancing accessibility of therapeutics across various healthcare facilities is anticipated to accelerate the market growth.

Osteoarthritis drugs refer to pharmaceutical agents and medications specifically designed or prescribed to manage the symptoms and slow the progression of osteoarthritis, a degenerative joint disease characterized by the breakdown of cartilage in the joints. These drugs encompass various classes of medications. They work through different mechanisms to alleviate pain, reduce inflammation, improve joint function, and potentially modify the underlying disease process.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The gas analyzer systems market in North America was reached USD 976.2 million in 2023 and is projected to record a CAGR of 5.3% through 2032, driven by the increasing adoption of online continuous monitoring systems and stringent environmental regulations aimed at reducing air pollution and emissions.

Electrochemical gas analyzer systems segment held a dominant market share in 2023 in North America and is poised to cross USD 460 million by 2032, driven by escalating emission levels across diverse end-use sectors.

U.S. gas analyzer systems industry surpass USD 1.10 billion by 2032, driven by the growing emphasis on improving industrial processes' efficiency and safety, along with technological advancements, particularly in sensor technology and data analytics.

ABB, Acoem., AMETEK. Inc., AVL, Dragerwerk AG & Co.KGaA, DURAG GROUP, Emerson ElectricCo.,ENVEA, Figaro Engineering Inc., General Electric, Honeywell International Inc are some of the major industry contenders.

Osteoarthritis Drugs Market Scope

Buy Now

Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 326
  • Countries covered: 19
  • Pages: 260
 Download Free Sample